593 related articles for article (PubMed ID: 11877485)
1. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.
Gumperz JE; Miyake S; Yamamura T; Brenner MB
J Exp Med; 2002 Mar; 195(5):625-36. PubMed ID: 11877485
[TBL] [Abstract][Full Text] [Related]
2. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
[TBL] [Abstract][Full Text] [Related]
3. Distinct functional lineages of human V(alpha)24 natural killer T cells.
Lee PT; Benlagha K; Teyton L; Bendelac A
J Exp Med; 2002 Mar; 195(5):637-41. PubMed ID: 11877486
[TBL] [Abstract][Full Text] [Related]
4. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
5. CD1d-restricted NKT cells: an interstrain comparison.
Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides.
Ortaldo JR; Young HA; Winkler-Pickett RT; Bere EW; Murphy WJ; Wiltrout RH
J Immunol; 2004 Jan; 172(2):943-53. PubMed ID: 14707067
[TBL] [Abstract][Full Text] [Related]
8. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers.
Matsuda JL; Naidenko OV; Gapin L; Nakayama T; Taniguchi M; Wang CR; Koezuka Y; Kronenberg M
J Exp Med; 2000 Sep; 192(5):741-54. PubMed ID: 10974039
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
10. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex.
Hansen DS; Siomos MA; Buckingham L; Scalzo AA; Schofield L
Immunity; 2003 Mar; 18(3):391-402. PubMed ID: 12648456
[TBL] [Abstract][Full Text] [Related]
11. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.
Metelitsa LS; Naidenko OV; Kant A; Wu HW; Loza MJ; Perussia B; Kronenberg M; Seeger RC
J Immunol; 2001 Sep; 167(6):3114-22. PubMed ID: 11544296
[TBL] [Abstract][Full Text] [Related]
12. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.
Durante-Mangoni E; Wang R; Shaulov A; He Q; Nasser I; Afdhal N; Koziel MJ; Exley MA
J Immunol; 2004 Aug; 173(3):2159-66. PubMed ID: 15265953
[TBL] [Abstract][Full Text] [Related]
13. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains.
Exley M; Porcelli S; Furman M; Garcia J; Balk S
J Exp Med; 1998 Sep; 188(5):867-76. PubMed ID: 9730888
[TBL] [Abstract][Full Text] [Related]
14. CD1d-independent developmental acquisition of prompt IL-4 gene inducibility in thymus CD161(NK1)-CD44lowCD4+CD8- T cells is associated with complementarity determining region 3-diverse and biased Vbeta2/Vbeta7/Vbeta8/Valpha3.2 T cell receptor usage.
Chen YT; Kung JT
J Immunol; 2005 Nov; 175(10):6537-50. PubMed ID: 16272308
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver.
Exley MA; He Q; Cheng O; Wang RJ; Cheney CP; Balk SP; Koziel MJ
J Immunol; 2002 Feb; 168(4):1519-23. PubMed ID: 11823474
[TBL] [Abstract][Full Text] [Related]
16. Rapid development of a gamma interferon-secreting glycolipid/CD1d-specific Valpha14+ NK1.1- T-cell subset after bacterial infection.
Emoto M; Yoshizawa I; Emoto Y; Miamoto M; Hurwitz R; Kaufmann SH
Infect Immun; 2006 Oct; 74(10):5903-13. PubMed ID: 16988270
[TBL] [Abstract][Full Text] [Related]
17. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.
Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD
J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408
[TBL] [Abstract][Full Text] [Related]
18. IL-15 expands unconventional CD8alphaalphaNK1.1+ T cells but not Valpha14Jalpha18+ NKT cells.
Terabe M; Tagaya Y; Zhu Q; Granger L; Roederer M; Waldmann TA; Berzofsky JA
J Immunol; 2008 Jun; 180(11):7276-86. PubMed ID: 18490727
[TBL] [Abstract][Full Text] [Related]
19. CD1d-restricted "NKT" cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses?
Gumperz JE
J Leukoc Biol; 2004 Aug; 76(2):307-13. PubMed ID: 15123775
[TBL] [Abstract][Full Text] [Related]
20. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
Lang GA; Exley MA; Lang ML
Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]